Circulating DNA changes are predictive of disease progression after transarterial chemoembolization. Sefrioui D, Verdier V, Savoye-Collet C, Beaussire L, et al. Int J Cancer 2022;150:532-541.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sefrioui D, Verdier V, Savoye-Collet C, Beaussire L, et al. Circulating DNA changes are predictive of disease progression after transarterial chemoembolization. Int J Cancer 2022;150:532-541.
PMID: 34622951